Johnson, Mats
University of Gothenburg
8 papers on CoChatORCID 0000-0001-5195-3379
Most cited papers
- Verified
Computerized training of working memory in children with ADHD – a randomized, controlled trial
Klingberg, T., Fernell, E., Olesen, P. J., Johnson, M., Gustafsson, P., Dahlström, K., Gillberg, C. G., Forssberg, H., & Westerberg, H. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderCognitive Abilities and Testing
Cited by 1,949
- Verified
Omega-3/Omega-6 Fatty Acids for Attention Deficit Hyperactivity Disorder: A Randomized Placebo-Controlled Trial in Children and Adolescents
Johnson, M., Östlund, S., Fransson, G., Kadesjö, B., & Gillberg, C. (2009) · Journal of Attention Disorders
Fatty Acid Research and HealthAttention Deficit Hyperactivity Disorder
Cited by 198
- Verified
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
Coghill, D., Banaschewski, T., Lecendreux, M., Soutullo, C., Johnson, M., Zuddas, A., Anderson, C., Civil, R., Higgins, N., Lyne, A., et al. (2013) · European Neuropsychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 123
- Verified
Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Banaschewski, T., Johnson, M., Lecendreux, M., Zuddas, A., Adeyi, B., Hodgkins, P., Squires, L. A., & Coghill, D. R. (2014) · CNS Drugs
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 41
- Verified
A comparison of North American versus non-North American ADHD study populations
Buitelaar, J. K., Barton, J., Danckaerts, M., Friedrichs, E., Gillberg, C., Hazell, P. L., Hellemans, H., Johnson, M., Kalverdijk, L. J., Masi, G., et al. (2006) · European Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development
Cited by 38
- Verified
Lisdexamfetamine Dimesylate: A New Therapeutic Option for Attention-Deficit Hyperactivity Disorder
Steer, C., Froelich, J., Soutullo, C. A., Johnson, M., & Shaw, M. (2012) · CNS Drugs
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 30
- Verified
Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (pediatric acute-onset neuropsychiatric syndrome): a systematic review
Johnson, M., Ehlers, S., Fernell, E., Hajjari, P., Wartenberg, C., & Wallerstedt, S. M. (2021) · PLOS ONE
Infectious Encephalopathies and EncephalitisAutoimmune Neurological Disorders and Treatments
Cited by 25
- Verified
Neurodevelopmental problems, general health and academic achievements in a school‐based cohort of 11‐year‐old Swedish children
Landgren, V., Svensson, L., Törnhage, C., Theodosious, M., Gillberg, C., Johnson, M., Knez, R., & Landgren, M. (2024) · Acta Paediatrica
Child and Adolescent Psychosocial and Emotional DevelopmentAttention Deficit Hyperactivity Disorder
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free